Iopamiro 150

Iopamidol, the active ingredient in Iopamiro 150, is an iodinated contrast media presented as a 150 mg I/mL injectable solution for intravenous use. It enhances radiographic imaging of blood vessels and tissues during diagnostic procedures, helping clinicians obtain clearer images for accurate diagnosis.

GNH USA supplies Iopamiro 150 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Iopamiro 150, an iodinated contrast agent, is used to improve visualization of vascular and organ structures in radiographic examinations.

- Computed tomography (CT) scans: provides enhanced contrast to delineate vascular and soft‑tissue structures. - Angiography: highlights blood vessels to aid in the assessment of arterial and venous anatomy. - Urography: improves the definition of urinary tract anatomy for functional and structural evaluation. - Myelography: enhances the spinal canal and nerve root imaging during contrast studies. - Cardiac catheterisation: increases contrast between cardiac chambers and vessels for precise procedural guidance.

Iopamiro 150 may cause a range of adverse reactions, from mild to severe. Awareness of these effects helps clinicians monitor patients during and after administration.

Common Side Effects: - Warmth or flushing sensation at the injection site. - Metallic taste in the mouth. - Nausea or mild vomiting. - Transient headache or dizziness.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reactions, including bronchospasm. - Acute kidney injury, especially in patients with pre‑existing renal impairment. - Severe hypotension or cardiovascular collapse. - Pulmonary edema or acute respiratory distress. - Cardiac arrhythmias in susceptible individuals.

Prior to using Iopamiro 150, clinicians should consider several safety measures to minimise risk.

- Assess renal function: evaluate serum creatinine and eGFR before administration. - Review iodine allergy history: avoid in patients with known hypersensitivity to iodinated contrast. - Use the lowest effective dose: tailor volume to the specific imaging protocol. - Monitor vital signs: observe blood pressure and heart rate during injection. - Caution in thyroid disease: avoid in uncontrolled hyperthyroidism or thyroid storm. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Iopamiro 150 can interact with other medications, requiring careful management.

Major Interactions (Avoid): - Concurrent use of other iodinated contrast agents: increases cumulative iodine load. - High‑dose metformin in patients with renal impairment: risk of lactic acidosis. - Nephrotoxic drugs (e.g., aminoglycosides, NSAIDs): may exacerbate renal injury.

Moderate Interactions (Monitor Closely): - Thyroid hormone therapy: contrast may affect thyroid function tests. - Diuretics: may alter fluid balance and affect contrast distribution. - Beta‑blockers: monitor for potential changes in heart rate during injection.